Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Columbia University Irving Medical Center · Cancer Genetics (United States) · +13 more institutions
Abstract
The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation…
Citation impact
- FWCI
- 28.48
- Percentile
- 100%
- References
- 28
Authors
24- DRDevendra Raj SinghCorresponding
Columbia University Irving Medical Center, Cancer Genetics (United States)
- JMJoseph M. ChanCorresponding
Columbia University Irving Medical Center
- PZPietro ZoppoliCorresponding
Columbia University Irving Medical Center, Cancer Genetics (United States)
- FNFrancesco NiolaCorresponding
Columbia University Irving Medical Center, Italian Institute of Technology, Cancer Genetics (United States)
- RJRyan J. Sullivan
Columbia University Irving Medical Center, Cancer Genetics (United States)
Topics & keywords
- Biology
- Fusion gene
- Oncogene Proteins
- Fusion protein
- Fibroblast growth factor receptor
- Carcinogenesis
- Gene
- Cancer research
- Good health and well-being